TY  - GEN
AU  - Graham,B S
AU  - Matthews,T J
AU  - Belshe,R B
AU  - Clements,M L
AU  - Dolin,R
AU  - Wright,P F
AU  - Gorse,G J
AU  - Schwartz,D H
AU  - Keefer,M C
AU  - Bolognesi,D P
TI  - Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network
SN  - 0022-1899
PY  - 1993///0330
KW  - AIDS Vaccines
KW  - immunology
KW  - Amino Acid Sequence
KW  - Binding, Competitive
KW  - Blotting, Western
KW  - CD4-Positive T-Lymphocytes
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Gene Products, env
KW  - biosynthesis
KW  - HIV Antibodies
KW  - HIV Envelope Protein gp120
KW  - HIV Envelope Protein gp160
KW  - HIV Envelope Protein gp41
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Immunization, Secondary
KW  - Molecular Sequence Data
KW  - Neutralization Tests
KW  - Peptide Fragments
KW  - Protein Precursors
KW  - Recombinant Proteins
KW  - Time Factors
KW  - Vaccinia virus
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1093/infdis/167.3.533
ER  -